LL-37 & CAP-18 Antibodies

Santa Cruz Biotechnology features a diverse variety of LL-37 & CAP-18 monoclonal antibodies for research focused on understanding antimicrobial peptides. LL-37 & CAP-18 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LL-37, the only human cathelicidin, plays a crucial role in innate immunity by exhibiting antimicrobial activity against a wide range of pathogens. CAP-18, a precursor molecule, is involved in the regulation of immune responses and inflammation. Understanding LL-37 and CAP-18 mechanisms provides valuable insights into host defense systems and potential therapeutic strategies for infectious diseases. Researchers can investigate the relationship between LL-37, CAP-18, and various physiological processes using specific detection methods. Advanced research techniques allow for detailed analysis of antimicrobial peptide expression patterns and functional characteristics. Investigating LL-37 and CAP-18 activity contributes to the development of novel therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support breakthrough discoveries in antimicrobial peptide research, advancing our understanding of immune system function and disease treatment.